Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03750942
Other study ID # NL63259.068.17
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 1, 2019
Est. completion date March 1, 2023

Study information

Verified date November 2018
Source Maastricht University Medical Center
Contact Nicole D Bouvy, MD, PhD
Phone +3143-3875492
Email n.bouvy@mumc.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Rationale:

Approximately 7000 stomata are created in the Netherlands every year. The occurrence of a parastomal herniation is high, with a reported incidence of 4-48%. Also, the former stoma site is at increased risk for the development of an incisional hernia. A clinical incisional hernia rate of 30% is reported after stoma reversal. Herniation can cause pain, deformity and possibly incarceration, which results in a significant impact on the quality of life of the patient.

The hypothesis of this study is that the use of a prophylactic mesh at the time of stoma formation leads to a lower incidence of incisional hernias after stoma reversal, an improved quality of life and therefore a possible cost reduction in healthcare.

Objective:

To evaluate the incidence of incisional hernias after stoma reversal after preventive mesh placement compared to no mesh placement. In addition, we aim to assess the effect of preventive mesh placement on the quality of life and the effect on healthcare cost reduction by avoiding re-intervention.

Study design:

A multicentre double blind randomized controlled trial with a total follow up of 24 months.

Study population:

Adults (18-99) undergoing bowel resection with the formation of a temporary stoma.

Intervention:

A preventive mesh will be placed using a sublay keyhole technique (pre-peritoneal, retromuscular) at stoma formation. The mesh will be left in situ after stoma reversal and the hole in the mesh will be closed, to prevent incisional herniation.

Main study parameters/endpoints:

- Primary: Incidence of incisional hernias after stoma reversal

- Secondary: Quality of life, stoma related prolapse or parastomal herniation, cost effectiveness and mesh related complications.

Nature and extent of the burden and the risks associated with participation, benefit and group relatedness:

The standard surgical procedure for the treatment of parastomal hernias is used in a prophylactic fashion. As this is standard care in parastomal hernias the risks are minimal. The mesh that is used is CE approved. The burden of participation in this study is minimal for the patient all follow-up visits coincide with the regular visits for colorectal cancer. Hence, no extra outpatient department visits, and even no additional diagnostics nor other medical procedures that could potentially burden the patient, are required.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 130
Est. completion date March 1, 2023
Est. primary completion date March 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- Age = 18 years

- Diagnosed with colorectal carcinoma

- Bowel resection following stoma formation, intended to be temporary.

- Elective surgery

- ASA-score I-III

- Signed informed consent

Exclusion Criteria:

- Emergency operation

- Peritonitis (i.e. bowel perforation)

- Bowel obstruction

- A life expectancy of less than 2 years (distant metastasis i.e. located in the liver, peritoneum, lung, cerebral or bone)

- Earlier hernia repair with mesh placed in a 10cm proximity of the future stoma site.

- Chronic use of antibiotics

- Chronic use of immunosuppressive medication

- ASA-score IV or above

- Not able to sign informed consent

- Patient being unable to speak Dutch

- Patient allergic to one of the components of the mesh

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Adhesix® monofilament polypropylene mesh (Bard Davol)
The intervention group will receive preventive mesh placement and in the control group no mesh is placed, the stoma is closed according to standard practise.

Locations

Country Name City State
Netherlands Maastricht University Medical Centre Maastricht Limburg

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence of incisional hernia at the former stoma site. Incidence of incisional hernia Expressed in % ranging from 0-100%, a lower percentage is considered a better outcome. 24 months
Secondary Occurrence of parastomal hernia Incidence of parastomal hernia Expressed in % ranging from 0-100%, a lower percentage is considered a better outcome. 24 months
Secondary Occurence of prolapse Incidence of prolapse Expressed in % ranging from 0-100%, a lower percentage is considered a better outcome. 24 months
Secondary Occurence of mesh infection Incidence of mesh infection Expressed in % ranging from 0-100%, a lower percentage is considered a better outcome. 24 months
Secondary Occurence of wound infections Incidence of wound infections Expressed in % ranging from 0-100%, a lower percentage is considered a better outcome. 24 months
Secondary Occurence of Seroma Incidence of seroma Expressed in % ranging from 0-100%, a lower percentage is considered a better outcome. 24 months
Secondary Quality of life score Quality of life postoperatively assessed through questionnaires.
- EQ-5D-5L (0-25), lower is considered a better outcome
24 months
Secondary Quality of life score Quality of life postoperatively assessed through questionnaires.
- Carolina Comfort scale (0-40), lower is considered a better outcome.
24 months
Secondary Quality of life score Quality of life postoperatively assessed through questionnaires.
- EORTC QLQ-CR29 (0-228), lower is considered a better outcome.
24 months
Secondary Operation length Time from start of the operation to finish (min), longer operation time can be an indication of a more complex procedure. during operation
Secondary Time to stoma reversal Time between creation of the stoma and its reversal, will be expressed in days. (minimum of 14 days to a maximum of 730 days). It will be measured from creation of stoma to reversal, which is 6 weeks on average, if the stoma is not reversed within 24 months the patient is excluded. For it will not be able to reach the primary endpoint. Delay of reversal of the stoma may indicate that patient condition or other patient related factors are not optimal. time from stoma creation to reversal
Secondary Cost-effectiveness Cost benefit analysis involving health cost and societal cost due to inability to participate in work. Lower health care cost are considered a better outcome, it is hypothesised that preventive treatment results in less cost by avoiding reoperations and readmission on the long term.
Assessment will be performed using questionnaires; the iMCQ questionnaires for cost effectiveness analysis.
The questions of the questionnaire will be analysed separately, for the questions range from yes/no questions to multiple choice or questions regarding number of days/ hours worked.
24 months
Secondary Cost-effectiveness Cost benefit analysis involving health cost and societal cost due to inability to participate in work. Lower health care cost are considered a better outcome, it is hypothesised that preventive treatment results in less cost by avoiding reoperations and readmission on the long term.
Assessment will be performed using questionnaires; the iPCQ questionnaires for cost effectiveness analysis.
The questions of the questionnaire will be analysed separately, for the questions range from yes/no questions to multiple choice or questions regarding number of days/ hours worked.
24 months
See also
  Status Clinical Trial Phase
Recruiting NCT06016426 - Mass Closure vs Layer by Layer Closure N/A
Recruiting NCT05734222 - Optimization of Surgical Treatment of Patients With Incisional Ventral Hernias N/A
Enrolling by invitation NCT03105895 - Prevention of Incisional Hernia With an Onlay Mesh Visible on MRI N/A
Completed NCT01961687 - A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair. N/A
Completed NCT02089958 - Standardization of Laparoscopic Hernia Repair N/A
Completed NCT00998907 - PDS*Plus and Wound Infections After Laparotomy N/A
Terminated NCT00498810 - COMplete Versus PArtial Open inCisional Hernia Repair (COMPAC-TRIAL) N/A
Completed NCT04961346 - RCT Comparing Lightweight vs. Heavyweight Meshes in Incisional Hernia Repair N/A
Terminated NCT03912662 - ProGripTM Self-Gripping Polyester Mesh in Incisional Hernia Prevention N/A
Recruiting NCT05620121 - ACute Treatment of Incisional Ventral Hernia
Recruiting NCT03561727 - Risk Factors for Development of Incisional Hernia in Transverse Incisions N/A
Completed NCT03938688 - Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation N/A
Not yet recruiting NCT05568238 - Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated Fascial Traction in Patients With Open Abdomen N/A
Not yet recruiting NCT02896686 - Efficacy of an Onlay Mesh for Prevention of Incisional Hernia After Loop Ileostomy Closure Phase 4
Recruiting NCT02277262 - PROPHYlactic Implantation of BIOlogic Mesh in Peritonitis (PROPHYBIOM) Phase 4
Active, not recruiting NCT02328352 - "BP as a New Device for Surgery and Solid Cancer and Hematopoietic System Tumors Treatment. Effects of BP Implantation" Phase 1/Phase 2
Suspended NCT01520168 - Composix Kugel Mesh Recall Leaves Unresolved Problems of Patient Management N/A
Completed NCT05579652 - Change in Fascial Tension in Open Abdomens
Active, not recruiting NCT03390764 - Hernia After Colorectal Cancer Surgery N/A
Completed NCT02321059 - Validation of the Goodstrength System for Assessment of Abdominal Wall Strength in Patients With Incisional Hernia N/A